Table 2 Patient characteristics and prescribed medication(s), by diagnosis
From: Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study
Diagnosis categories, n (%) | All 1 497 (100) | Diabetes 481 (32) | Heart failure 192 (13) | Hypertension 1 191 (80) | No diabetes or heart failure 888 (59) | |
|---|---|---|---|---|---|---|
Age, years, mean (SD) | 77 (11) | 75 (10) | 80 (10) | 77 (10) | 77 (11) | |
eGFR, ml/min/1.73 m2, median (IQR) | 53 (44‒61) | 53 (42‒71) | 48 (38‒57) | 53 (44‒62) | 53 (46‒60) | |
UACR, mg/g, median (IQR) | 33 (11‒85) | 46 (18‒116) | 22 (9‒79) | 36 (11‒88) | 27 (9‒74) | |
UACR, n (%) | 0‒30 mg/g | 475 (32) | 143 (30) | 58 (30) | 384 (32) | 296 (33) |
30‒300 mg/g | 458 (31) | 197 (41) | 39 (20) | 402 (34) | 237 (27) | |
 > 300 mg/g | 97 (7) | 44 (9) | 8 (4) | 81 (7) | 50 (6) | |
Missing | 467 (31) | 97 (20) | 87 (45) | 324 (27) | 305 (34) | |
ACEi/ARB | 973 (65) | 364 (76) | 142 (74) | 901 (76) | 518 (58) | |
Beta-blocker | 562 (38) | 202 (42) | 129 (67) | 479 (40) | 274 (31) | |
CCB | 565 (38) | 197 (41) | 46 (24) | 534 (45) | 341 (38) | |
Loop-diuretic | 393 (26) | 153 (32) | 130 (68) | 324 (27) | 157 (18) | |
Thiazide | 350 (23) | 122 (25) | 14 (7) | 334 (28) | 218 (25) | |
MRA | 124 (8) | 52 (11) | 53 (28) | 105 (9) | 39 (4) | |
SGLT2i | 215 (14) | 182 (38) | 54 (28) | 180 (15) | 12 (1) | |
GLP-1 RA | 119 (8) | 107 (22) | 22 (12) | 102 (9) | 9 (1) | |
Statin | 845 (56) | 367 (76) | 125 (65) | 708 (59) | 402 (45) | |
NSAID | 84 (6) | 25 (5) | 10 (5) | 66 (6) | 53 (6) | |
OAC | 786 (53) | 268 (56) | 153 (80) | 640 (54) | 415 (47) | |